Evidence map›Paper›PMID 31746962›Full record

ArticleJAMA cardiology2020

Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.

Eythór Björnsson, Guðmar Thorleifsson, Anna Helgadóttir, Thórarinn Guðnason, Tómas Guðbjartsson, Karl Andersen, Sólveig Grétarsdóttir, Ísleifur Ólafsson, Vinicius Tragante, Ólafur Hreiðar Ólafsson and 8 more

Open access · hybridAbstract read
In one paragraph

Article in JAMA cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. CD27 on IgD-CD38-B Cells Mediates the Coprococcus-COPD Link.International journal of chronic obstructive pulmonary disease · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Eythór BjörnssondeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Guðmar ThorleifssondeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Anna HelgadóttirdeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Thórarinn GuðnasonDivision of Cardiology, Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland.
Tómas GuðbjartssonFaculty of Medicine, University of Iceland, Reykjavík, Iceland.
Karl AndersenFaculty of Medicine, University of Iceland, Reykjavík, Iceland.
Sólveig GrétarsdóttirdeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Ísleifur ÓlafssonDepartment of Clinical Biochemistry, Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland.
Vinicius TragantedeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Ólafur Hreiðar ÓlafssondeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Birna JónsdóttirRöntgen Domus, Reykjavík, Iceland.
Guðmundur I EyjólfssonThe Laboratory in Mjódd, Reykjavík, Iceland.
Ólöf SigurðardóttirDepartment of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Guðmundur ThorgeirssondeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Daníel F GuðbjartssondeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Unnur ThorsteinsdóttirdeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Hilma HólmdeCODE genetics/Amgen Inc, Reykjavík, Iceland.
Kári StefánssondeCODE genetics/Amgen Inc, Reykjavík, Iceland.
deCODE Genetics (Iceland) · ISNational University Hospital of Iceland · ISUniversity of Iceland · ISAkureyri Hospital · ISUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Genetic studies have evaluated the influence of blood lipid levels on the risk of coronary artery disease (CAD), but less is known about how they are associated with the extent of coronary atherosclerosis. Objective: To estimate the contributions of genetically predicted blood lipid levels on the extent of coronary atherosclerosis. Design, Setting, and Participants: This genetic study included Icelandic adults who had undergone coronary angiography or assessment of coronary artery calcium using cardiac computed tomography. The study incorporates data collected from January 1987 to December 2017 in Iceland in the Swedish Coronary Angiography and Angioplasty Registry and 2 registries of individuals who had undergone percutaneous coronary interventions and coronary artery bypass grafting. For each participant, genetic scores were calculated for levels of non-high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides, based on reported effect sizes of 345 independent, lipid-associated variants. The genetic scores' predictive ability for lipid levels was assessed in more than 87 000 Icelandic adults. A mendelian randomization approach was used to estimate the contribution of each lipid trait. Exposures: Genetic scores for levels of non-HDL-C, LDL-C, HDL-C, and triglycerides. Main Outcomes and Measures: The extent of angiographic CAD and coronary artery calcium quantity. Results: A total of 12 460 adults (mean [SD] age, 65.1 [10.7] years; 8383 men [67.3%]) underwent coronary angiography, and 4837 had coronary artery calcium assessed by computed tomography. A genetically predicted increase in non-HDL-C levels by 1 SD (38 mg/dL [to convert to millimoles per liter, multiply by 0.0259]) was associated with greater odds of obstructive CAD (odds ratio [OR], 1.83 [95% CI, 1.63-2.07]; P = 2.8 × 10-23). Among patients with obstructive CAD, there were significant associations with multivessel disease (OR, 1.26 [95% CI, 1.11-1.44]; P = 4.1 × 10-4) and 3-vessel disease (OR, 1.47 [95% CI, 1.26-1.72]; P = 9.2 × 10-7). There were also significant associations with the presence of coronary artery calcium (OR, 2.04 [95% CI, 1.70-2.44]; P = 5.3 × 10-15) and loge-transformed coronary artery calcium (effect, 0.70 [95% CI, 0.53-0.87]; P = 1.0 × 10-15). Genetically predicted levels of non-HDL-C remained associated with obstructive CAD and coronary artery calcium extent even after accounting for the association with LDL-C. Genetically predicted levels of HDL-C and triglycerides were associated individually with the extent of coronary atherosclerosis, but not after accounting for the association with non-HDL cholesterol. Conclusions and Relevance: In this study, genetically predicted levels of non-HDL-C were associated with the extent of coronary atherosclerosis as estimated by 2 different methods. The association was stronger than for genetically predicted levels of LDL-C. These findings further support the notion that non-HDL-C may be a better marker of the overall burden of atherogenic lipoproteins than LDL-C.

Indexed as

AgedCausalityCholesterolCholesterol, HDLCholesterol, LDLCoronary AngiographyCoronary Artery DiseaseFemaleGenetic Predisposition to DiseaseGenotypeHumansHyperlipidemiasIcelandLogistic ModelsMaleMendelian Randomization AnalysisCholesterolCholesterol, HDLCholesterol, LDLTriglycerides

Identifiers

PMID31746962
PMCPMC6902100
OpenAlexW2991599651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.